Gallbladder Cancer Surgery in Uberlândia-MG

In early stages, gallbladder cancer is usually asymptomatic and is often an incidental finding after cholecystectomy for gallstones. When present, symptoms include persistent pain in the right upper quadrant of the abdomen, unintentional weight loss, nausea, and a palpable mass. In bile duct tumors, jaundice (yellowing of the skin and eyes), dark urine, and pale stools are warning signs that require prompt medical evaluation.

Diagnosis combines imaging studies: abdominal ultrasound, computed tomography, and magnetic resonance imaging with MRCP, which assess local extension and the bile duct. In selected cases, endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous cholangiography complement the workup. Serum tumor markers, such as CA 19-9 and CEA, assist in monitoring but do not confirm the diagnosis on their own — histological confirmation depends on biopsy or analysis of the surgical specimen.

Duration varies according to the extent of the procedure. A simple cholecystectomy may take 1 to 2 hours; a radical cholecystectomy with liver resection and lymphadenectomy, or surgery for cholangiocarcinoma with major hepatectomy and biliary reconstruction, usually takes between 4 and 8 hours. The exact time depends on anatomy, staging, and intraoperative findings, and is detailed individually during preoperative planning.

Surgery is performed under general anesthesia, with continuous monitoring and, frequently, the addition of epidural analgesia or other multimodal analgesia techniques for postoperative pain control. The choice of anesthetic technique is determined by the anesthesiologist together with the surgical team, considering the anticipated extent of the operation, comorbidities, and the patient's individual clinical condition.

Length of hospital stay varies with the complexity of the procedure. Simpler cholecystectomies usually require 1 to 3 days of hospitalization; radical surgeries with liver resection, lymphadenectomy, or biliary reconstruction generally require 5 to 10 days, and may extend depending on clinical progress. Discharge is determined individually, based on recovery of bowel function, pain control, and the absence of complications.

Pain intensity varies according to the surgical approach and the extent of the surgery — laparoscopic procedures tend to cause less discomfort than more extensive open resections. Control is achieved with multimodal analgesia, combining intravenous medications, epidural analgesia when indicated, and, later, oral medication, adjusted according to each patient's individual response throughout recovery.

Yes, in most larger surgeries for gallbladder or bile duct cancer, the use of an abdominal drain is common, to monitor secretions and identify any biliary fistulas early, along with a urinary catheter during the perioperative period. The duration of these devices is individualized, and they are progressively removed according to clinical progress, generally still during hospitalization.

In laparoscopic cholecystectomies, scars are usually small, typically consisting of 3 to 4 incisions of a few millimeters each. In radical surgeries involving associated liver resection, a larger incision — subcostal or midline — may be necessary to allow adequate access to the liver and bile duct. The surgical approach (open, laparoscopic, or robotic) is determined according to disease extent and the conditions of each case.

Time away from work varies according to the extent of the surgery and the type of professional activity. After simpler cholecystectomies, return to light activities usually occurs between 2 and 4 weeks; after radical surgeries with liver resection, the recovery period is longer, potentially taking 6 to 8 weeks or more. Return to work should be assessed individually, according to each patient's progress.

As with any major abdominal surgery, there are risks of bleeding, infection, biliary fistula, intra-abdominal fluid collections, and anesthesia-related complications, which vary according to the extent of resection. Surgeries involving associated hepatectomy may carry a risk of liver failure. The surgical indication depends on staging, clinical condition, and the patient's functional reserve — in very advanced or disseminated disease, surgery may not be indicated, and other therapeutic modalities may be prioritized instead.

Not always. The need for adjuvant chemotherapy, or, in selected cases, radiotherapy or chemoradiotherapy, depends on staging, surgical margins, and the results of the histopathological analysis of the specimen. Treatment is conducted by a multidisciplinary team, including a digestive tract oncologic surgeon, clinical oncologist, radiation oncologist, radiologist, pathologist, and nutritional support team, with decisions discussed jointly according to the particularities of each case.